Paul Armentano

Advisor
Paul Armentano

Paul Armentano is the Deputy Director of NORML, the National Organization for the Reform of Marijuana Laws, and also serves as a faculty member at Oaksterdam University. His writing and research have appeared in over 750 publications, scholarly and/or peer-reviewed journals, as well as in more than a dozen textbooks and anthologies. He is a regulator contributor to TheHill.com as well as to numerous other print and online publications, including Freedom Leaf and Alternet.org. Mr. Armentano is the co-author of the book Marijuana is Safer: So Why Are We Driving People to Drink? (2009, Chelsea Green), which has been licensed and translated internationally. His most recent book, The Citizen’s Guide to State-By-State Marijuana Laws (2015), is available from Whitman Publishing. He is the 2013 Freedom Law School Health Freedom Champion of the Year and the 2013 Alfred R. Lindesmith award recipient in the achievement in the field of scholarship. Mr. Armentano was the principle investigator for defense counsel in US v Schweder, the first federal evidentiary since 1973 hearing to challenge the constitutionality of cannabis as a schedule I controlled substance. He was also an expert in a successful Canadian constitutional challenge (Crown v Allard) preserving qualified patients right to grow cannabis at home. Mr. Armentano previously provided online content to TheAnswerPage.com, an online medical educational resource that provides daily education to healthcare professionals in 120 countries, as well as Continuing Medical Education credit. A version of this curriculum is now required in New York State for any physician who wishes to participate in the state’s medical cannabis program.

Blog

Soroptimist Live Your Dream Awards Ready to begin a new life? The Soroptimist Live Your Dream: Education & Training...
Some of the Obvious Ways Marijuana Benefits Society Less obesity and greater workforce participation are just two of the many benefits. Access to...
10 biggest pot myths, debunked by science By any objective analysis, cannabis and cannabinoids exceed the FDA’s existing standards for...
NORML Responds To National Academy of Sciences' Marijuana Report Washington, DC: The National Academy of Sciences, Engineering, and Medicine released a...